Monday, July 30, 2018

Amgen Adds To Sutro Biopharma Investment

Thousand Oaks-based Amgen has returned as one of the investors in cancer therapeutis developer Sutro Biopharma, as part of an $85.4M funding round. South San Francisco-based Sutro Biopharma said last week that it has raised $85.4M in a Series E funding round. The fun

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.